Chemical Compound

Nebramycin V'

CAS Registry Number 51736-77-7
Back to search Request a Quote
Nebramycin V' chemical structure
Primary Record

Nebramycin V'

In stock
1,810 g
Purity
98.1 %
CAS
51736-77-7

Compound Identifiers & Properties

CAS
51736-77-7
PubChem CID
197189
SMILES
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)COC(=O)N)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N
Canonical SMILES
NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](COC(N)=O)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O

Names & Synonyms

  • Nebramycin V'
  • 6''-O-Carbamoyltobramycin
  • Nebramycin factor 5'
  • nebramycin 5'
  • Nebramycin-5'
  • tobramycin carbamate
  • 6-O-Carbamoyltob
  • Carbamoyltobramycin
  • Tobramycin Impurity N1
  • Tobramycin Impurity 10
  • RefChem:103620
  • 51736-77-7
  • CHEBI:73686
  • AC1L531Q
  • 6 -O-Carbamyltobramycin
  • SCHEMBL30687245
  • DTXSID10966042
  • UNII-837245T11O
  • C19H38N6O10
  • BBF-02106
  • CID197189
  • 837245T11O
  • C19-H38-N6-O10
  • LS-146888
  • J1.293.010K
  • C18001
  • [(2R,3S,4S,5R,6S)-4-amino-6-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-3,5-dihydroxyoxan-2-yl]methyl carbamate
  • Q27143854
  • (1S,2S,3R,4S,6R)-4,6-diamino-3-[(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-6-O-carbamoyl-3-deoxy-alpha-D-glucopyranoside
  • [(2R,3S,4S,5R,6S)-4-amino-6-[(1S,2S,3R,4S,6R)-4,6-diamino-3-
  • D-Streptamine, O-3-amino-6-O-(aminocarbonyl)-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1-4))-2-deoxy-
  • ((2R,3S,4S,5R,6S)-4-amino-6-(((1S,2S,3R,4S,6R)-4,6-diamino-3-(((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-3,5-dihydroxytetrahydro-2H-pyran-2-yl)methyl carbamate
  • (1S,2S,3R,4S,6R)-4,6-diamino-3-((2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl)oxy)-2-hydroxycyclohexyl 3-amino-6-O-carbamoyl-3-deoxy-alpha-D-glucopyranoside
  • (1S,2S,3R,4S,6R)-4,6-Diamino-3-[(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-6-O-[hydroxy(imino)methyl]-alpha-D-glucopyranoside
  • [(2R,3S,4S,5R,6S)-4-AMINO-6-{[(1S,2S,3R,4S,6R)-4,6-DIAMINO-3-{[(2R,3R,5S,6R)-3-AMINO-6-(AMINOMETHYL)-5-HYDROXYOXAN-2-YL]OXY}-2-HYDROXYCYCLOHEXYL]OXY}-3,5-DIHYDROXYOXAN-2-YL]METHYL CARBAMATE
  • 6-O-(3-Amino-6-O-carbamoyl-3-deoxy-alpha-D-glucopyranosyl)-4-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl)-2-deoxy-D-streptamine
  • 6-O-(6-O-Carbamoyl-3-amino-3-deoxy-alpha-D-glucopyranosyl)-4-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl)-2-deoxy-D-streptamine
  • D-STREPTAMINE, O-3-AMINO-6-O-(AMINOCARBONYL)-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(2,6-DIAMINO-2,3,6-TRIDEOXY-.ALPHA.-D-RIBO-HEXOPYRANOSYL-(1->4))-2-DEOXY-
  • D-Streptamine, O-3-amino-6-O-(aminocarbonyl)-3-deoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1.fwdarw.4)]-2-deoxy-
  • O-3-AMINO-6-O-(AMINOCARBONYL)-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(2,6-DIAMINO-2,3,6-TRIDEOXY-.ALPHA.-D-RIBO-HEXOPYRANOSYL-(1->4))-2-DEOXY-D-STREPTAMINE